Report cover image

United States Market for In Vitro Diagnostic (IVD) Tests

Publisher Kalorama Information
Published Jun 01, 2021
Length 187 Pages
SKU # KLI16717620

Description

United States Market for In Vitro Diagnostic (IVD) Tests

The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world.

COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict how the coronavirus will impact the forecast years to 2025, but Kalorama has attempted to provide insight into the industry by conversing with market participants and government entities. It is realistic to assume the market for COVID-19 will remain a component of the IVD market as the continued prevalence of the virus and the evolving variants are expected to remain. It should be noted that the market can be uncertain and ongoing research will help determine the long-term path of the segment in the coming months to years.

Demographic aging is also one of the primary market influencing trends for IVD in the United States. Aging is associated with rising incidences and rates of prevalence for several non-infectious diseases including diabetes and cancer. Individuals over the age of 60 are estimated to average at least four times the number of clinical tests of younger individuals.

This latest report from Kalorama Information, United States Market for In Vitro Diagnostic Tests, discusses these and other trends shaping the present and future of the IVD market in America. The report discusses the following IVD market segments in the United States:
  • Clinical Chemistry
  • Microbiology (Traditional) – Identification and Antibiotic Susceptibility Testing (ID/AST)
  • Microbiology – Molecular- Infectious Disease
  • Point-of-Care (POC) Tests – Diabetes
  • Point-of-Care (POC) Tests – All Other
  • Immunoassays – Infectious Disease (non-POC)
  • Immunoassays – Other
  • Molecular - Non-infectious Disease
  • Hematology
  • Coagulation (non-POC)
  • Histology
  • Blood Testing and Typing
  • Others
In addition, the report profiles the top players in the U.S. IVD market. The profiles cover notable corporate events and developments from 2018, 2019 and 2020. Featured companies include:
  • Abbott Diagnostics
  • Beckman Coulter, Inc. / Danaher
  • Becton, Dickinson and Company (BD)
  • bioMérieux
  • Bio-Rad Laboratories, Inc.
  • Cepheid / Danaher
  • Danaher Corporation
  • Hologic, Inc.
  • Ortho Clinical Diagnostics (Ortho)
  • QIAGEN N.V.
  • Roche Diagnostics
  • Siemens Healthineers (Siemens)
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Table of Contents

187 Pages
    • U.S. IVD Market
    • Top Tier U.S. IVD Market Participants and Rankings
    • Conclusions
    • The United States and In Vitro Diagnostics
    • U.S. Patient Population
    • Clinical Testing under Medicare – Reimbursement Cuts and Market-Based Pricing
    • Personalized Medicine and NGS
    • Laboratory-Developed Tests (LDTs)
    • U.S. Healthcare Infrastructure and Testing Channels
    • Conclusions
    • Clinical Chemistry
    • Microbiology and Virology – ID/AST and Molecular
    • Point-of-Care Testing
    • Immunoassays
    • Molecular Non-Infectious Disease Diagnostics
    • Coagulation
    • Histology
    • Hematology
    • Blood Testing and Typing
    • Total U.S. IVD Market
    • Abbott Diagnostics
    • Beckman Coulter, Inc. / Danaher
    • Becton, Dickinson and Company (BD)
    • bioMérieux
    • Bio-Rad Laboratories, Inc.
    • Cepheid / Danaher
    • Danaher Corporation
    • Hologic, Inc.
    • Ortho Clinical Diagnostics (Ortho)
    • QIAGEN N.V.
    • Roche Diagnostics
    • Siemens Healthineers (Siemens)
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us